Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination.
about
Dependency of Vaccine Efficacy on Pre-Exposure and Age: A Closer Look at a Tetravalent Dengue Vaccine.Dengue virus non-structural protein 1: a pathogenic factor, therapeutic target, and vaccine candidateImmunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults
P2860
Integrated immunogenicity analysis of a tetravalent dengue vaccine up to 4 y after vaccination.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Integrated immunogenicity anal ...... e up to 4 y after vaccination.
@en
type
label
Integrated immunogenicity anal ...... e up to 4 y after vaccination.
@en
prefLabel
Integrated immunogenicity anal ...... e up to 4 y after vaccination.
@en
P2093
P2860
P1476
Integrated immunogenicity anal ...... e up to 4 y after vaccination.
@en
P2093
Aline Richetin
Claire Vigne
Danaya Chansinghakul
Eric Plennevaux
Fernando Noriega
Martin Dupuy
Matthew Bonaparte
Melanie Saville
P2860
P304
P356
10.1080/21645515.2017.1333211
P577
2017-06-09T00:00:00Z